ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder

Human Pathology

Volumn 45, Issue 11, 2014, Pages 2233-2239

  Faraj, Sheila F ^a   Chaux, Alcides ^a,b   Gonzalez Roibon, Nilda ^a   Munari, Enrico ^a   Ellis, Carla ^a   Driscoll, Tina ^c   Schoenberg, Mark P ^c   Bivalacqua, Trinity J ^c   Shih, Ie Ming ^a,c   Netto, George J ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Universidad del Norte School of Medicine   (Paraguay)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

ARID1A; BAF250A; Bladder cancer; NMI BC; Prognosis

Indexed keywords

AT RICH INTERACTIVE DOMAIN 1A PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ARID1A PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER MORTALITY; CANCER PROGNOSIS; CONTROLLED STUDY; CYSTECTOMY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PROTEIN EXPRESSION; RISK FACTOR; SCORING SYSTEM; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; TUMOR INVASION; UROTHELIAL CARCINOMA OF THE BLADDER; YOUDEN INDEX; CARCINOMA, TRANSITIONAL CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84908349473     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.07.003     Document Type: Article

References (25)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. E.M. Wolff, G. Liang, and P.A. Jones Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer Nat Clin Pract Urol 2 2005 502 510
3. Z. Kirkali, T. Chan, and M. Manoharan Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 2005 4 34
4. J.W. Oosterhuis, R.F. Schapers, M.L. Janssen-Heijnen, R.P. Pauwels, D.W. Newling, and F. ten Kate Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems J Clin Pathol 55 2002 900 905
5. H.W. Herr, S.M. Donat, and V.E. Reuter Management of low grade papillary bladder tumors J Urol 178 2007 1201 1205 [discussion 1205]
6. H. Miyamoto, F. Brimo, and L. Schultz Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center Arch Pathol Lab Med 134 2010 1160 1163
7. A. Chaux, S. Karram, and J.S. Miller High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center Hum Pathol 43 2012 115 120
8. J.N. Eble, G. Sauter, J.I. Epstein, and I.A. Sesterhenn World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon
9. M.F. Botteman, C.L. Pashos, A. Redaelli, B. Laskin, and R. Hauser The health economics of bladder cancer: a comprehensive review of the published literature Pharmacoeconomics 21 2003 1315 1330
10. A. Ayhan, T.L. Mao, and T. Seckin Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma Int J Gynecol Cancer 22 2012 1310 1315
11. S. Jones, M. Li, and D.W. Parsons Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types Hum Mutat 33 2012 100 103
12. J.N. Wu, and C.W. Roberts ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 3 2013 35 43
13. B. Guan, T.L. Wang, and I. Shih ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers Cancer Res 71 2011 6718 6727
14. Y. Gui, G. Guo, and Y. Huang Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder Nat Genet 43 2011 875 878
15. C. Balbas-Martinez, M. Rodriguez-Pinilla, and A. Casanova ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors PLoS One 8 2013 e62483
16. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti American Joint Committee on Cancer Staging Manual 7th ed. 2010 Springer New York
17. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
18. B. Guan, T.L. Mao, and P.K. Panuganti Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma Am J Surg Pathol 35 2011 625 632
19. E.F. Schisterman, N.J. Perkins, A. Liu, and H. Bondell Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples Epidemiology 16 2005 73 81
20. D.R. Anderson Model Based Inference in the Life Sciences: A Primer on Evidence 2008 Springer New York 51 82
21. R Core Team R: A language and environment for statistical computing 2013 R Foundation for Statistical Computing Vienna, Austria [ http://www.R-project.org ]
22. G.J. Netto Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a mirage? Adv Anat Pathol 20 2013 175 203
23. R.J. Kurman, and I. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm Hum Pathol 42 2011 918 931
24. T. Bosse, N.T. Ter Haar, and L.M. Seeber Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer Mod Pathol 11 2013 1525 1535
25. R.L. Camp, V. Neumeister, and D.L. Rimm A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers J Clin Oncol 26 2008 5630 5637